Authors


Farzaneh Shirani, MD

Latest:

Emergency Department Nonurgent Visits in Iran: Prevalence and Associated Factors

Inappropriate use of emergency department resources in Iran is a frequent problem that calls for effective approaches and interventions.


Nikoletta M. Margaretos, BA

Latest:

Patients’ Access to 2018 FDA-Approved Drugs 1 Year Post Approval

2018 was a landmark year for new drug approvals. However, patients’ access to these novel drugs varied by drug category and enrolled health plan.



Rachel R. Bailey, MPH

Latest:

Economic Model for Emergency Use Authorization of Intravenous Peramivir

The US Food and Drug Administration granted emergency use authorization of intravenous neuraminidase inhibitors for patients with 2009 influenza A (H1N1), creating a need for economic studies.


Elizabeth G. Liles, MD

Latest:

More Comprehensive Discussion of CRC Screening Associated With Higher Screening

More comprehensive discussion of colorectal screening by primary care physicians was associated with higher screening rates among adults aged 51 to 80 years who were overdue for screening.




Anjali Sharma, MD

Latest:

Cost Per Response Analysis of Strategies for Chronic Immune Thrombocytopenia

This decision tree model estimates the cost per response and incremental cost per additional responder for romiplostim, eltrombopag, and “watch and rescue” for immune thrombocytopenia.


Laura Mortkowitz

Latest:

The Great Biomarker Chase

Promise and Pitfalls Along the Path to Personalized Care


Rebecca A. Malouin, PhD, MPH, MS

Latest:

Multipayer Primary Care Transformation: Impact for Medicaid Managed Care Beneficiaries

The Michigan Primary Care Transformation project generated cost savings among adults in Medicaid managed care, particularly high-risk adults, while largely maintaining quality of care.


Sean Bowman, MPH

Latest:

Evaluating the Efficacy of a Bundled Chronic Condition Management Program

A chronic disease management company presents promising preliminary results from their remote intensive behavioral counseling intervention, aimed at addressing type 2 diabetes.


Krista Drobac

Latest:

Telehealth: An Important Tool in Achieving the Goals of the ACO Program and Why Restrictions Should Be Lifted in Final ACO Rule

Lifting section 1834(m) restrictions on telehealth services would help ACOs to utilize this beneficial tool to achieve their cost, quality, access, and patient engagement goals.





Katerine Dea, MSc

Latest:

Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung Cancer

This review assesses the current molecular testing landscape for non–small-cell lung cancer in the United States.



Elise M. Pelletier, MS

Latest:

Patient Out-of-Pocket Payments for Oral Oncolytics: Results From a 2009 US Claims Data Analysis

Out-of-pocket payments differ widely among oral oncolytic options. As cost for therapy becomes a greater part of treatment decisions, an understanding of patient out-of-pocket cost will be critical in informing choices.



Brock O&rsquo

Latest:

The Influence of Provider Characteristics and Market Forces on Response to Financial Incentives

We determine a specialist physician phenotype responsive to financial incentives that may be leveraged to identify physicians and markets well-suited for participation in alternative payment models.


J. Frank Wharam, MB, BCh, BAO, MPH

Latest:

The Promise and Peril of Healthcare Forecasting

Healthcare forecasting could facilitate personalized insurance benefit design and clinical decision support systems, although increased socioeconomic disparities could result from selective disease management programs.


Sara Young, MBA

Latest:

Bridges to Excellence—Recognizing High-Quality Care: Analysis of Physician Quality and Resource Use

Physicians recognized as high quality by Bridges to Excellence performed better than their peers on claimsbased quality measures and, in some cases, on resource use measures.



Miles Masatsugu, MD

Latest:

The Impact of Patient Assistance Programs and the 340B Drug Pricing Program on Medication Cost

Examining the financial impact that patient assistance programs and the 340B Drug Pricing Program have on improving medication cost.


Steven R. Erickson, PharmD

Latest:

Medication Adherence: The Search for Interventions That Work

Current interventions to improve medication adherence lack a clear, uniform approach by which patient compliance can be universally improved.



Philip H. Sive, MD

Latest:

The Patient’s Photograph in the Medical Record as a Diagnostic Tool

Two case reports are presented in which previous photographs of the patients appearing in their medical record were of considerable assistance in making the diagnosis.


Arnona Ziv, MBA

Latest:

Disease Management Programs: Barriers and Benefits

Perceived barriers and benefits to implementing disease management programs among Israeli healthcare leaders could assist other countries faced with increasing numbers of chronically ill patients.


Yiduo Zhang, PhD

Latest:

Outcomes and Lessons Learned From Evaluating TRICARE's Disease Management Programs

Findings from TRICARE's disease management programs for asthma, congestive heart failure, and diabetes patients suggest that the programs more than pay for themselves.


Jason P. Smith, PharmD

Latest:

Evaluation of Human Immunodeficiency Virus and Hepatitis C Telemedicine Clinics

In an integrated health system, human immunodeficiency virus and hepatitis C telemedicine clinics are associated with improved access, high patient satisfaction, and reduction in health visit“related time.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo